Association between expedited review designations and the US or global burden of disease for drugs approved by the US Food and Drug Administration 2010-2019 medrxiv.org/content/10.1101/20

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.